Literature DB >> 16774251

Enantioselective synthesis of ferrocenyl nucleoside analogues with apoptosis-inducing activity.

Philippe James1, Jörg Neudörfl, Moritz Eissmann, Patrick Jesse, Aram Prokop, Hans-Günther Schmalz.   

Abstract

[reaction: see text] As a contribution to bioorganometallic chemistry, an enantioselective synthesis of novel carbocyclic nucleoside analogues with a ferroceno-cyclopentene backbone was developed. Diastereoselective cuprate 1,4-addition or Mukaiyama-Michael addition to a planar-chiral enoate (ethyl (E)-2-[2-methoxycarbonyl-ferrocenyl]-acrylate) allowed for the introduction of different side chains (RCH(2)). Other important steps include a Dieckmann cyclization and the attachment of the nucleobase (NB) in an iron-assisted S(N)1 reaction. Some of the target compounds were shown to exhibit significant apoptosis-inducing activity (LD(50) = 10-20 microM) against tumor cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16774251     DOI: 10.1021/ol060868f

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  10 in total

1.  Synthesis, characterization and cytotoxic studies of water soluble [(η-C(5)H(5))(2)Mo(thionucleobase/thionucleoside)]Cl complexes in breast and colon cancer cell lines.

Authors:  Débora Acevedo-Acevedo; Jaime Matta; Enrique Meléndez
Journal:  J Organomet Chem       Date:  2011-03-01       Impact factor: 2.369

2.  Iron containing anti-tumoral agents: unexpected apoptosis-inducing activity of a ferrocene amino acid derivative.

Authors:  Benjamin Kater; Andrea Hunold; Hans-G Schmalz; Lisa Kater; Birgit Bonitzki; Patrick Jesse; Aram Prokop
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-11       Impact factor: 4.553

Review 3.  Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.

Authors:  Mehvash Zaki; Suboot Hairat; Elham S Aazam
Journal:  RSC Adv       Date:  2019-01-24       Impact factor: 4.036

4.  Stereoselective Synthesis and Anticancer Activity of 2,6-Disubstituted trans-3-Methylidenetetrahydropyran-4-ones.

Authors:  Tomasz Bartosik; Joanna Drogosz-Stachowicz; Anna Janecka; Jacek Kędzia; Barbara Pacholczyk-Sienicka; Jacek Szymański; Katarzyna Gach-Janczak; Tomasz Janecki
Journal:  Materials (Basel)       Date:  2022-04-21       Impact factor: 3.748

Review 5.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

6.  Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden.

Authors:  Christian Prinz; Elena Vasyutina; Gregor Lohmann; Alexandra Schrader; Steffen Romanski; Christoph Hirschhäuser; Petra Mayer; Corazon Frias; Carmen D Herling; Michael Hallek; Hans-Günther Schmalz; Aram Prokop; Dimitrios Mougiakakos; Marco Herling
Journal:  Mol Cancer       Date:  2015-06-04       Impact factor: 27.401

7.  A new generation of ferrociphenols leads to a great diversity of reactive metabolites, and exhibits remarkable antiproliferative properties.

Authors:  Yong Wang; Patrick M Dansette; Pascal Pigeon; Siden Top; Michael J McGlinchey; Daniel Mansuy; Gérard Jaouen
Journal:  Chem Sci       Date:  2017-11-16       Impact factor: 9.825

8.  Synthesis, structure, electrochemistry, and cytotoxic properties of ferrocenyl ester derivatives.

Authors:  Li Ming Gao; Ramón Hernández; Jaime Matta; Enrique Meléndez
Journal:  Met Based Drugs       Date:  2009-03-24

Review 9.  New trends for metal complexes with anticancer activity.

Authors:  Pieter C A Bruijnincx; Peter J Sadler
Journal:  Curr Opin Chem Biol       Date:  2008-01-25       Impact factor: 8.822

10.  Purine and Purine Isostere Derivatives of Ferrocene: An Evaluation of ADME, Antitumor and Electrochemical Properties.

Authors:  Valentina Rep; Martina Piškor; Helena Šimek; Petra Mišetić; Petra Grbčić; Jasna Padovan; Vesna Gabelica Marković; Dijana Jadreško; Krešimir Pavelić; Sandra Kraljević Pavelić; Silvana Raić-Malić
Journal:  Molecules       Date:  2020-03-29       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.